Lifestyle imagery of a man and woman hiking with canyon peaks in the background.

Proven to help lower your LDL-C & keep it there

At 1 year, studies showed that more than:

90%

of adults taking LEROCHOL lowered their LDL-C levels down to target.

People at very high risk aimed to lower their LDL-C by 50% or more and reach levels below 55 mg/dL. Those at high risk aimed to lower their LDL-C by 50% or more and reach levels below 70 mg/dL.

LEROCHOL made the difference for adults with:

LEROCHOL lowered
LDL-C by about

60%

Results maintained through week 52

ASCVD includes risk for heart attack or stroke caused by plaque buildup in your arteries.

ApoB, a protein carrying
bad cholesterol, went down by about

46%

Across studies, LEROCHOL helped lower certain proteins linked to heart disease:

Lp(a), a protein linked
to heart disease, went down by about

33%

Possible side effects of LEROCHOL

The most common side effects of LEROCHOL include injection site reactions such as redness, itching, swelling, pain, bruising, or tenderness, runny or stuffy nose and sore throat (nasopharyngitis), diarrhea, nausea, and swelling of the arms, hands, legs, or feet (peripheral edema). These are not all the possible side effects of LEROCHOL. Tell your healthcare provider if you have any side effect that bothers you or does not go away.

ApoB, apolipoprotein B; ASCVD, atherosclerotic cardiovascular disease; HeFH, heterozygous familial hypercholesterolemia; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a).

IMPORTANT SAFETY INFORMATION

DO NOT USE LEROCHOL® if you are allergic to lerodalcibep or to any of the ingredients in LEROCHOL.

What is LEROCHOL?

LEROCHOL is a prescription injectable medicine used along with diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad cholesterol,” in adults with hypercholesterolemia (high cholesterol), including heterozygous familial hypercholesterolemia (HeFH). It is not known if LEROCHOL is safe and effective in children.

Before using LEROCHOL

Before starting LEROCHOL, tell your healthcare provider, including your pharmacist, about all your medical conditions, including if you are pregnant or plan to become pregnant, are breastfeeding or plan to breastfeed, or if you take other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Using LEROCHOL

Use LEROCHOL exactly as your healthcare provider tells you to use it. LEROCHOL is a subcutaneous injection (under the skin) self-administered one time every month. If your healthcare provider decides that you or a caregiver can give the injections, you should receive training on the proper injection technique. Do not stop using LEROCHOL without talking to your healthcare provider, as cholesterol levels may increase if treatment is stopped.

What are the possible side effects of LEROCHOL?

The most common side effects of LEROCHOL include injection site reactions such as redness, itching, swelling, pain, bruising, or tenderness, runny or stuffy nose and sore throat (nasopharyngitis), diarrhea, nausea, and swelling of the arms, hands, legs, or feet (peripheral edema). These are not all the possible side effects of LEROCHOL. Tell your healthcare provider if you have any side effect that bothers you or does not go away.

Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs. Contact us at 1‑877‑2‑LEROCHOL (1‑877‑253‑7624) or the FDA by visiting www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information.

You are about to leave the LEROCHOL.com website and enter a website operated by a third party.
LIB Therapeutics is not responsible for and does not endorse or control the content contained
on this third-party website.

By clicking “Continue” below, you acknowledge that you have read and reviewed
the information contained within the Notice of Third-Party Site.

Continue

The information on this site is intended for US healthcare professionals only.

Yes